切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - AXL - Flk1 - DOT1L - Glucocorticoid Receptors

11件产品中的 1-10

页面
每页
清除全部
  1. TP-0903
    B5940 TP-0903
    中文名: 度博替尼
    Target: AXL
    Summary: AXL受体酪氨酸激酶抑制剂,抗癌药
      ≥25.8 mg/mL
      insoluble in H2O
  2. Methylprednisolone Sodium Succinate
    B4953 Methylprednisolone Sodium Succinate
    中文名: 甲泼尼龙琥珀酸钠
    Target: Glucocorticoid Receptors
    Summary: 糖皮质激素
      ≥49.7 mg/mL
      ≥2.94 mg/mL
  3. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  4. EPZ004777 HCl
    B1581 EPZ004777 HCl
    Target: DOT1L
    Summary: DOT1L抑制剂
      ≥16.5 mg/mL
      insoluble in H2O
  5. Fluticasone propionate
    B2096 Fluticasone propionate
    中文名: 丙酸氟替卡松
    Target: Glucocorticoid Receptors
    Summary: 高亲和力,选择性糖皮质激素受体激动剂
      ≥18.5 mg/mL
      insoluble in H2O
  6. Dexamethasone acetate
    B1926 Dexamethasone acetate
    中文名: 醋酸地塞米松
    Target: Glucocorticoid Receptors|interleukin receptor
    Summary: IL受体调节剂
      ≥13.35 mg/mL
      insoluble in H2O
  7. Mifepristone
    B1511 Mifepristone
     3 Citation
    中文名: 美服培酮
    Target: Progesterone Receptors|Glucocorticoid Receptors
    Summary: 孕激素受体拮抗剂
      ≥21.48 mg/mL
      insoluble in H2O
  8. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  9. EPZ004777
    A4170 EPZ004777
    Target: DOT1L
    Summary: DOT1L抑制剂
      ≥27 mg/mL
      insoluble in H2O
  10. Methylprednisolone
    A4233 Methylprednisolone
    中文名: 甲泼尼龙
    Target: Glucocorticoid Receptors
    Summary: 细胞凋亡诱导剂,GR激动剂
      ≥15.35 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页